Two Years of Genomic Surveillance in Belgium during the SARS-CoV-2 Pandemic to Attain Country-Wide Coverage and Monitor the Introduction and Spread of Emerging VariantsArticle Published on 2022-10-202022-11-15 Journal: Viruses [Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘, 진단, [키워드] Belgium country COVID-19 effort genomic genomic sequencing Genomic surveillance intensity Laboratory Lineage Next-generation sequencing performed Quality control Research SARS-CoV-2 SARS-CoV-2 genome SARS-CoV-2 genomic surveillance Surveillance the SARS-CoV-2 variant variants of concern Year [DOI] 10.3390/v14102301 PMC 바로가기
Saliva testing among teachers during the COVID-19 pandemic: Effects on health concerns, well-being, and precautionary behaviorResearch article Published on 2022-10-012022-10-05 Journal: Social science & medicine (1982) [Category] 진단, [키워드] adherence age Belgium Cluster collected control group COVID-19 Critical Decline decrease detect diagnostic Effect Effects experimental group Health Health concerns impacted implementation increase in Intensive less linear Measures not affect objective outbreak Outbreaks pandemic participant participated positive Prevent rationale Regression model Result Saliva saliva test Saliva testing SARS-CoV-2 School School principal support Schools secure Support supported tested [DOI] 10.1016/j.socscimed.2022.115295 [Article Type] Research article
Prevalence, incidence and longevity of antibodies against SARS-CoV-2 among primary healthcare providers in Belgium: a prospective cohort study with 12 months of follow-upArticle Published on 2022-09-192022-11-15 Journal: BMJ Open [Category] SARS, 변종, 진단, [키워드] 95% CI age antibody asked Belgium booster vaccination Care circulation cohort study Complete COVID-19 COVID-19 infection dominant eight eligible Epidemiology Follow-up general medicine (see internal medicine) Health Healthcare provider IgM and IgG incidence internal Longevity measure natural infection participant Participants participated Patient patients physically Prevalence primary care Prospective prospective cohort study provided questionnaire reached Receptor binding domain Registered SARS-CoV-2 SARS-CoV-2 antibody secondary outcome serological test supported vaccination variant virus women [DOI] 10.1136/bmjopen-2022-065897 PMC 바로가기
Locked up at home: a cross-sectional study into the effects of COVID-19 lockdowns on domestic violence in households with children in BelgiumArticle Published on 2022-09-102022-11-16 Journal: BMC Public Health [Category] 치료기술, [키워드] Acute stress added age aggression association Belgium children Clustering Coping strategy COVID-19 COVID-19 pandemic cross-sectional cumulative detect domestic violence Effect effort evaluate Factor First wave FIVE Follow-up Gender healthcare worker helping IMPROVE increase in limit lockdown Logistic regression measure Measures mental health Occurrence parent Perceived stress positive Prevalence Public public health risk risk factor School sexual Sexual and gender based violence. Spread Stress virus was used while [DOI] 10.1186/s12889-022-14135-3 PMC 바로가기
Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trialArticle Published on 2022-09-072022-10-06 Journal: The Lancet. Respiratory Medicine [Category] COVID19(2023년), SARS, 진단, [키워드] 1:1 95% CI Acute kidney injury acute respiratory distress addition all-cause mortality all-cause mortality rate Analysis antibody assigned Belgium Block randomisation Brazil C5a Critically ill defined determine died dose double-blind eligible excluded France Germany hazard ratio hospital hospital discharge IMPROVE intravenously intubation invasive Invasive mechanical ventilation ITT analysis Kaplan-Meier analysis matching placebo mechanically ventilated patient monoclonal antibody Mortality multicentre Netherlands Older one patient outcome PaO participant Patient patient population phase 2 trial phase 3 trial Placebo placebo-controlled Pneumonia primary analysis Primary outcome random assignment randomised Randomly receive receiving reduced Registered reported Research Russia Safe safety analysis SARS-COV-2 infection Septic shock shown significant decrease significantly South Africa Standard of care survival TEAE the placebo group therapy Treatment treatment-emergent adverse event variant vilobelimab viral infections was performed with COVID-19 [DOI] 10.1016/S2213-2600(22)00297-1 PMC 바로가기 [Article Type] Article
The role of airborne transmission in a large single source outbreak of SARS-CoV-2 in a Belgian nursing home in 2020Article Published on 2022-09-012023-07-09 Journal: Epidemics [Category] COVID19(2023년), [키워드] Airborne transmission Belgium COVID-19 nursing home outbreak Outbreak investigation SARS-CoV-2 Transmission [DOI] 10.1016/j.epidem.2022.100589 PMC 바로가기
Perspectives of public health professionals on border control practices for COVID-19 management in EuropeResearch article Published on 2022-09-012022-10-05 Journal: Public health [Category] 변종, [키워드] analysed asked Belgium border control carried conducted consequence COVID-19 COVID-19 pandemic effective Effectiveness English Europe European French Germany Health Impact Infectious disease interview management measure mitigate Netherland objective outbreak pandemic participant performed Perspective professional Public public health Public health professionals Qualitative qualitative research raised reducing Region regions Research Result semistructured interview spread of COVID-19 union [DOI] 10.1016/j.puhe.2022.06.020 [Article Type] Research article
SARS-CoV-2 surveillance in Norway rats (Rattus norvegicus) from Antwerp sewer system, BelgiumArticle Published on 2022-09-012022-11-15 Journal: Transboundary and emerging diseases [Category] SARS, 변종, 진단, [키워드] activity addition analysed anti-SARS-CoV-2 IgG antibody Antwerp Belgium checked collected COVID-19 epidemic cVNT disease disease outbreaks evaluate Evolution faece human-to-animal transmission humans immunoassay infect infected with SARS-CoV-2 Interpretation Local MIA microsphere Muridae neutralizing antibody Norway oral swabs outbreak positive RATs Rattus reservoir rodents RT-qPCR Sample SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RNA SARS-CoV-2 surveillance screened sera serological test serum serum sample tested tissue tissue sample variant viral neutralization was tested [DOI] 10.1111/tbed.14219 PMC 바로가기
Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational studyResearch article Published on 2022-08-242022-10-05 Journal: The Lancet. Respiratory Medicine [Category] COVID19(2023년), SARS, 바이오마커, 유전자 메커니즘, 진단, [키워드] admitted to ICU Affect affecting Analysis Antwerp Aspergillus autophagy Belgium Bronchoalveolar lavage fluid bronchoalveolar lavage sample bronchoalveolar lavage samples calculate Cell chemokines collected Concentration conidia COVID-19 Critically ill patient Cytokines development diagnose differentially expressed disrupting downregulated downregulation elevated Eligible patients encoding protein enrichment analysis epithelial European expression expression data finding foundation fraction France function funding Gene expression analysis growth factor Horizon hospital hyphae ICU IFNγ IL-1β Immunity in vivo increased mortality Influenza Influenza virus Innate immunity intensive care invasive invasive ventilation investigated kill killing lung epithelial Max Planck Society network neutrophil Neutrophils Non-invasive pathophysiology pathway Pathway analysis Pathways Patient patients patients with COVID-19 patients with influenza performed phagocytosis Protein recruited Regional retrieved SARS-COV-2 infection SARS-CoV-2 RNA several gene significantly significantly lower spores TNF-α tracheobronchial transcriptomics Treatment Type I IFN type II IFN university University Hospitals Leuven were used [DOI] 10.1016/S2213-2600(22)00259-4 [Article Type] Research article
Poor Antibody Response to BioNTech/Pfizer Coronavirus Disease 2019 Vaccination in Severe Acute Respiratory Syndrome Coronavirus 2-Naive Residents of Nursing HomesBioNTech/Pfizer 코로나바이러스 질병 2019 중증 급성 호흡기 증후군 코로나바이러스 백신 접종에 대한 항체 반응 불량Article Published on 2022-08-242022-09-11 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 변종, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus administration age antibody Antibody Response B.1.351 B.1.351 variant Belgium binding antibodies binding antibody BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccination Breakthrough infection cluster analysis comorbid conditions comparable coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 death detectable disease domain domains dose General population heterogeneity high risk home immunization Immunoglobulin immunosenescence IMPROVE in some Infection involved Messenger RNA mRNA mRNA vaccination mRNA vaccine Neutralizing Nursing nursing homes old age Poor RBD RBD IgG recruited related disease resident respiratory respond poorly Responder response S1 and S2 SARS-CoV-2 severe acute respiratory syndrome Coronavirus Support the vaccine These data vaccination Vaccine vaccine strain variants variants of concern were assessed wild type [DOI] 10.1093/cid/ciab998 PMC 바로가기 [Article Type] Article